Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-27

Clinical Trial Update: Pimecrolimus and Epidermal Barrier Function [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of pimecrolimus on epidermal barrier function in individuals with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimecrolimus (pimecrolimus)

Snippet

Sponsor: University of Kiel | Conditions: Atopic Dermatitis | NA | Status: COMPLETED